ArticleJournal of Cancer2022

Development and Validation of a Combined Hypoxia and Immune Prognostic Classifier for Lung Adenocarcinoma.

Hua Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.